In vivo evaluation of percutaneous carbon dioxide treatment for improving intratumoral hypoxia using 18F-fluoromisonidazole PET-CT.
Maruyama K, Okada T, Ueha T, Isohashi K, Ikeda H, Kanai Y, Sasaki K, Gentsu T, Ueshima E, Sofue K, Nogami M, Yamaguchi M, Sugimoto K, Sakai Y, Hatazawa J, Murakami T.
Maruyama K, et al. Among authors: sasaki k.
Oncol Lett. 2021 Mar;21(3):207. doi: 10.3892/ol.2021.12468. Epub 2021 Jan 14.
Oncol Lett. 2021.
PMID: 33574946
Free PMC article.